v3.26.1
Financial Instruments - Schedule of Changes in Contingent Consideration Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 29, 2026
Mar. 30, 2025
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning $ 1,790 $ 517
Changes in estimated fair value [1] 295 8
Additions 0 0
Settlements and other (45) (48)
Transfer into/(out of) Level 3 0 0
Fair value, ending $ 2,041 $ 477
[1] Reported in Other (income)/deductions––net. See Note 4. The amount in the first quarter of 2026 is primarily related to our acquisition of Metsera.